Monogram Biosciences (MGRM) Reaffirms FY08 Sales Guidance; Provides Update on Oncology Programs
Tweet Send to a Friend
Monogram Biosciences, Inc. (Nasdaq: MGRM) today reaffirmed its FY08 guidance for sales in excess of $60 million.
William ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
William ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
